Changhua Christian Hospital
Changhua, 500, Taiwan
NCT Number: NCT03798418
The objective of this study is to investigate the effects of therapeutic exercise and nutrition intervention for sarcopenia and risk of falls in patients with major chronic diseases. The outcomes will be analyzed regarding muscle strength, quality, and volume, etc., balance and gait, bone density, body composition, fall and quality of life after the intervention.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Changhua, 500, Taiwan
The main common chronic diseases in the elderly such as stroke, osteoporosis, chronic kidney disease and cancer, have been regarded as the fall high-risk patients. These patients are considered to be at risk for sarcopenia due to decreased exercise, nutritional status, and other reasons. Sarcopenia can be diagnosed and intervened effectively to delay the vicious cycle of health. Past studies have pointed out that in addition to drug intervention, treatment for sarcopenia must be accompanied by appropriate exercise and nutritional intervention (such as protein supplements, vitamin D) in order to achieve the best prevention and treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
2-3days per week(150min per week)
Other names: thera-band strengthening exercise
each patients in this group will receive4-5times diet counseling
Other names: nutrition counseling
Time frame: baseline: before intervention; follow-up: 3 months after intervention
distance: 6m, patients can walk with foor orthosis and assistive devices
Time frame: before intervention; follow-up: 3 months after intervention
Use a grip force meter (kg) to test both hands for test 3 times
Time frame: before intervention; follow-up: 3 months after intervention
Use computerized dynography to measure the postural sway displacement (mm)
Time frame: before intervention; follow-up: 3 months after intervention
Use computerized dynography to measure the postural sway velocity (mm/s)
Time frame: before intervention; follow-up: 3 months after intervention
Use computerized dynography to measure the postural sway area (mm^2)
Time frame: before intervention; follow-up: 3 months after intervention
Use computerized dynography to measure spatial gait parameter: step time (ms)
Time frame: before intervention; follow-up: 3 months after intervention
Use computerized dynography to measure spatial gait parameter: stance time (ms)
Time frame: before intervention; follow-up: 3 months after intervention
Use computerized dynography to measure spatial gait parameter: swing time (ms)
Time frame: before intervention; follow-up: 3 months after intervention
Use computerized dynography to measure spatial gait parameter: single support time (ms)
Time frame: before intervention; follow-up: 3 months after intervention
Use computerized dynography to measure spatial gait parameter: double support time (ms)
Time frame: before intervention; follow-up: 3 months after intervention
Use computerized dynography to measure spatial gait parameter: step distance (mm)
Time frame: before intervention; follow-up: 3 months after intervention
Use computerized dynography to measure spatial gait parameter: stance distance (mm)
Time frame: before intervention; follow-up: 3 months after intervention
Use ultrasound to assess muscles morphological parameter: thickness (mm). Target muscles include quadriceps, hamstring, anterior tibialis, gastrocnemius.
Time frame: before intervention; follow-up: 3 months after intervention
Use ultrasound to assess muscles morphological parameter: fiber length (mm). Target muscles include quadriceps, hamstring, anterior tibialis, gastrocnemius.
Time frame: before intervention; follow-up: 3 months after intervention
Use ultrasound to assess muscles morphological parameter: fiber orientation angle (degrees). Target muscles include quadriceps, hamstring, anterior tibialis, gastrocnemius.
Time frame: before intervention; follow-up: 3 months after intervention
Use ultrasound to assess muscles morphological parameter: cross-sectional area (mm^2).
Target muscles include quadriceps, hamstring, anterior tibialis, gastrocnemius.
Time frame: before intervention; follow-up: 3 months after intervention
Heart rate (HR: beats/min) and walking speed (m/s) have been previously shown to be linearly related to oxygen uptake at sub-maximal exercise levels. Combination of these two parameters yields a single value in beats per meter, the physiological cost index (PCI). This is calculated as Working HR - Resting HR (beats/min) / Walking speed (m/s)
Time frame: before intervention; follow-up: 3 months after intervention
including 8 health concepts: (1) physical functioning, (2) role limitations because of physical health problems; (3) bodily pain, (4) social functioning, (5) general mental health (psychological distress and psychological wellbeing), (6) role limitations because of emotional problems, (7) vitality (energy/fatigue), (8) general health perceptions.
Scoring: answers to each question are scored which are then summed and transformed to a 0 - 100 scale.
The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
Time frame: before intervention; follow-up: 3 months after intervention
use electromyography to measure the muscles activity in microvolts (uv) included quadriceps, hamstrings, tibialis anterior, gastrocnemius during subject walking in self-selected speed in 6 meters.
Time frame: before intervention; follow-up: 3 months after intervention
The concentration of CRP in the blood test. CRP is used mainly as a marker of inflammation.
Time frame: before intervention; follow-up: 3 months after intervention
The concentration of ALB in the blood test. Albumin is the most important contributor to the maintenance of plasma colloid oncotic pressure; deficiency results in edema.
Time frame: before intervention; follow-up: 3 months after intervention
The concentration of GFR in the blood test. The glomerular filtration rate is the best test to measure the patient's level of kidney function and determine the stage of kidney disease. It can calculate it from the results of the blood creatinine test.
Time frame: Time Frame: before intervention; follow-up: 3 months after intervention
The concentration of Hb in the blood test.
Time frame: Time Frame: before intervention; follow-up: 3 months after intervention
The concentration of Glucose SPOT in the blood test. TheSpot glucose measurement in epidermal interstitial fluid appears to be a promising alternative to capillary blood glucose estimation
Time frame: before intervention; follow-up: 3 months after intervention
The concentration of Cholesterol in the blood test.
Time frame: before intervention; follow-up: 3 months after intervention
The concentration of Triglyceride in the blood test.
Time frame: before intervention; follow-up: 3 months after intervention
The concentration of Transferrin in the blood test.
Time frame: before intervention; follow-up: 3 months after intervention
including 14 items which are scored on a 5 points scale (0-4). The degree of success in achieving each task is given a score of zero (unable) to four (independent), and the final measure is the sum of all of the scores.
The item scores are summed, minimum score =0, maximum score = 56
Time frame: before intervention; follow-up: 3 months after intervention
Items are scored on a 3-point ordinal scale (0 = cannot perform; 1 = performs partially; 2 = performs fully) Maximum Score = 226 points The 5 domains assessed include, Motor function (UE maximum score = 66; LE maximum score = 34), Sensory function (maximum score = 24), Balance (maximum score = 14), Joint range of motion (maximum score = 44), Joint pain (maximum score = 44)
Time frame: before intervention; follow-up: 3 months after intervention
(body weight) kg/(height) m*(height)m
Time frame: before intervention; follow-up: 3 months after intervention
It is an 11-question measure that tests five areas of cognitive function:
orientation, registration, attention and calculation, recall, and language. The maximum score is 30. A score of 23 or lower is indicative of cognitive impairment.
Time frame: before intervention; follow-up: 3 months after intervention
measures resistance during passive soft-tissue stretching, the score is ranged from 0-4 0: No increase in muscle tone
Time frame: before intervention; follow-up: 3 months after intervention
measure the muscle tone (kg/m) under muscle resting. Target muscles are quadricep, hamstring, anterior tibialis, gastrocnemius.
Changhua Christian Hospital
Other
Sarcopenia and Risk of Falls in Patients With Major Chronic Diseases - Effects of Therapeutic Exercise and Nutrition Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03847753
Acquired Immunodeficiency Syndrome, Allergy
View Trial DetailsNCT06583395
Adnexal Diseases, Amyotrophic Lateral Sclerosis
Palm Desert, California, United States
View Trial DetailsNCT04663685
Arthritis, Behavior
Waterloo, Canada
View Trial DetailsNCT02742597
Alzheimer Disease, Alzheimer's Disease
London, Ontario, Canada
View Trial Details